Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Hyundai Bioscience announced that its COVID-19 oral drug solved Niclosamide's inhibitory concentration problem 2020-12-08 21:00
Hyundai Bioscience: A Korean bio-tech solves the bioavailability issue of Niclosamide 2020-10-29 20:00
'Curing Cancer without Surgery' 2020-06-30 15:10
1 2